vs

Side-by-side financial comparison of Ceribell, Inc. (CBLL) and MASIMO CORP (MASI). Click either name above to swap in a different company.

MASIMO CORP is the larger business by last-quarter revenue ($371.5M vs $24.8M, roughly 15.0× Ceribell, Inc.). MASIMO CORP runs the higher net margin — -27.0% vs -54.6%, a 27.6% gap on every dollar of revenue. MASIMO CORP produced more free cash flow last quarter ($50.9M vs $-11.0M).

Ceribell, Inc. develops and commercializes innovative portable neurodiagnostic medical devices, focused on rapid non-invasive electroencephalogram (EEG) solutions for seizure detection. Its core products serve hospital emergency departments, intensive care units, and long-term care facilities, with primary markets across North America and ongoing global expansion efforts.

Masimo Corporation is an American health technology and consumer electronics company headquartered in Irvine, California. The company develops patient monitoring devices, non-invasive sensors, and related software platforms used in hospital and home settings. Masimo has also operated in the consumer audio and wearable device markets.

CBLL vs MASI — Head-to-Head

Bigger by revenue
MASI
MASI
15.0× larger
MASI
$371.5M
$24.8M
CBLL
Higher net margin
MASI
MASI
27.6% more per $
MASI
-27.0%
-54.6%
CBLL
More free cash flow
MASI
MASI
$61.9M more FCF
MASI
$50.9M
$-11.0M
CBLL

Income Statement — Q4 2025 vs Q3 2026

Metric
CBLL
CBLL
MASI
MASI
Revenue
$24.8M
$371.5M
Net Profit
$-13.5M
$-100.4M
Gross Margin
87.3%
62.1%
Operating Margin
-58.9%
22.5%
Net Margin
-54.6%
-27.0%
Revenue YoY
-26.4%
Net Profit YoY
-1124.5%
EPS (diluted)
$-0.35
$-1.84

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBLL
CBLL
MASI
MASI
Q4 25
$24.8M
Q3 25
$22.6M
$371.5M
Q2 25
$21.2M
$370.9M
Q1 25
$20.5M
$372.0M
Q4 24
$600.7M
Q3 24
$17.2M
$504.6M
Q2 24
$496.3M
Q1 24
$492.8M
Net Profit
CBLL
CBLL
MASI
MASI
Q4 25
$-13.5M
Q3 25
$-13.5M
$-100.4M
Q2 25
$-13.6M
$51.3M
Q1 25
$-12.8M
$-170.7M
Q4 24
$-349.6M
Q3 24
$-10.4M
$9.8M
Q2 24
$16.0M
Q1 24
$18.9M
Gross Margin
CBLL
CBLL
MASI
MASI
Q4 25
87.3%
Q3 25
88.3%
62.1%
Q2 25
88.1%
62.9%
Q1 25
87.9%
62.9%
Q4 24
40.7%
Q3 24
87.3%
52.2%
Q2 24
51.3%
Q1 24
49.0%
Operating Margin
CBLL
CBLL
MASI
MASI
Q4 25
-58.9%
Q3 25
-64.8%
22.5%
Q2 25
-70.5%
17.4%
Q1 25
-69.3%
21.0%
Q4 24
-59.8%
Q3 24
-57.8%
6.0%
Q2 24
5.7%
Q1 24
6.9%
Net Margin
CBLL
CBLL
MASI
MASI
Q4 25
-54.6%
Q3 25
-59.6%
-27.0%
Q2 25
-64.4%
13.8%
Q1 25
-62.4%
-45.9%
Q4 24
-58.2%
Q3 24
-60.6%
1.9%
Q2 24
3.2%
Q1 24
3.8%
EPS (diluted)
CBLL
CBLL
MASI
MASI
Q4 25
$-0.35
Q3 25
$-0.37
$-1.84
Q2 25
$-0.38
$0.94
Q1 25
$-0.36
$-3.12
Q4 24
$-6.54
Q3 24
$-1.85
$0.18
Q2 24
$0.29
Q1 24
$0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBLL
CBLL
MASI
MASI
Cash + ST InvestmentsLiquidity on hand
$159.3M
$312.3M
Total DebtLower is stronger
$559.1M
Stockholders' EquityBook value
$155.3M
$810.0M
Total Assets
$195.8M
$1.8B
Debt / EquityLower = less leverage
0.69×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBLL
CBLL
MASI
MASI
Q4 25
$159.3M
Q3 25
$168.5M
$312.3M
Q2 25
$177.4M
$149.6M
Q1 25
$182.7M
$130.8M
Q4 24
$177.6M
Q3 24
$14.1M
$158.5M
Q2 24
$129.6M
Q1 24
$157.6M
Total Debt
CBLL
CBLL
MASI
MASI
Q4 25
Q3 25
$559.1M
Q2 25
$613.7M
Q1 25
$651.0M
Q4 24
$765.2M
Q3 24
$772.6M
Q2 24
$781.6M
Q1 24
$876.0M
Stockholders' Equity
CBLL
CBLL
MASI
MASI
Q4 25
$155.3M
Q3 25
$164.1M
$810.0M
Q2 25
$172.2M
$1.0B
Q1 25
$180.9M
$946.4M
Q4 24
$1.1B
Q3 24
$-136.0M
$1.5B
Q2 24
$1.4B
Q1 24
$1.4B
Total Assets
CBLL
CBLL
MASI
MASI
Q4 25
$195.8M
Q3 25
$199.5M
$1.8B
Q2 25
$207.7M
$2.4B
Q1 25
$213.5M
$2.3B
Q4 24
$2.6B
Q3 24
$47.1M
$3.1B
Q2 24
$2.9B
Q1 24
$3.0B
Debt / Equity
CBLL
CBLL
MASI
MASI
Q4 25
Q3 25
0.69×
Q2 25
0.59×
Q1 25
0.69×
Q4 24
0.73×
Q3 24
0.53×
Q2 24
0.57×
Q1 24
0.64×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBLL
CBLL
MASI
MASI
Operating Cash FlowLast quarter
$-10.8M
$56.8M
Free Cash FlowOCF − Capex
$-11.0M
$50.9M
FCF MarginFCF / Revenue
-44.2%
13.7%
Capex IntensityCapex / Revenue
0.7%
1.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-41.6M
$191.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBLL
CBLL
MASI
MASI
Q4 25
$-10.8M
Q3 25
$-11.1M
$56.8M
Q2 25
$-7.5M
$69.4M
Q1 25
$-11.4M
$31.1M
Q4 24
$50.5M
Q3 24
$25.6M
Q2 24
$74.5M
Q1 24
$45.8M
Free Cash Flow
CBLL
CBLL
MASI
MASI
Q4 25
$-11.0M
Q3 25
$-11.5M
$50.9M
Q2 25
$-7.6M
$65.6M
Q1 25
$-11.6M
$28.5M
Q4 24
$46.0M
Q3 24
$16.9M
Q2 24
$66.9M
Q1 24
$37.6M
FCF Margin
CBLL
CBLL
MASI
MASI
Q4 25
-44.2%
Q3 25
-50.8%
13.7%
Q2 25
-35.9%
17.7%
Q1 25
-56.4%
7.7%
Q4 24
7.7%
Q3 24
3.3%
Q2 24
13.5%
Q1 24
7.6%
Capex Intensity
CBLL
CBLL
MASI
MASI
Q4 25
0.7%
Q3 25
1.6%
1.6%
Q2 25
0.3%
1.0%
Q1 25
0.7%
0.7%
Q4 24
0.7%
Q3 24
1.7%
Q2 24
1.5%
Q1 24
1.7%
Cash Conversion
CBLL
CBLL
MASI
MASI
Q4 25
Q3 25
Q2 25
1.35×
Q1 25
Q4 24
Q3 24
2.61×
Q2 24
4.66×
Q1 24
2.42×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBLL
CBLL

Products$18.8M76%
Subscription$6.0M24%

MASI
MASI

Segment breakdown not available.

Related Comparisons